tradingkey.logo
tradingkey.logo
Pesquisar

Tempus AI Inc

TEM
Adicionar à lista de desejos
49.860USD
+0.390+0.79%
Fechamento 05/08, 16:00ETCotações atrasadas em 15 min
8.95BValor de mercado
PerdaP/L TTM

Mais detalhes de Tempus AI Inc Empresa

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Informações de Tempus AI Inc

Código da empresaTEM
Nome da EmpresaTempus AI Inc
Data de listagemMay 30, 2025
CEOLefkofsky (Eric P)
Número de funcionários2400
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 30
Endereço600 West Chicago Avenue
CidadeCHICAGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal60654
Telefone18335144187
Sitehttps://investors.tempus.com/
Código da empresaTEM
Data de listagemMay 30, 2025
CEOLefkofsky (Eric P)

Executivos da empresa Tempus AI Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
859.70K
+4.91%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
106.73K
+3.77%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
28.98K
+81.75%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
26.91K
+79.62%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
20.76K
+29.15%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
14.80K
+91.55%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
11.02K
+70.57%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
859.70K
+4.91%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
106.73K
+3.77%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
28.98K
+81.75%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
26.91K
+79.62%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
20.76K
+29.15%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
14.80K
+91.55%

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: há 2 horas
Atualizado em: há 2 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Blue Media, LLC
9.05%
BK TL21 LLC
7.36%
Lefkofsky (Eric Paul)
7.19%
ARK Investment Management LLC
5.41%
Gray Media, LLC
5.09%
Outro
65.90%
Investidores
Investidores
Proporção
Blue Media, LLC
9.05%
BK TL21 LLC
7.36%
Lefkofsky (Eric Paul)
7.19%
ARK Investment Management LLC
5.41%
Gray Media, LLC
5.09%
Outro
65.90%
Tipos de investidores
Investidores
Proporção
Investment Advisor
33.96%
Corporation
26.11%
Investment Advisor/Hedge Fund
10.97%
Individual Investor
8.02%
Hedge Fund
4.75%
Research Firm
4.00%
Holding Company
3.10%
Bank and Trust
1.09%
Venture Capital
0.89%
Outro
7.10%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
847
109.28M
62.62%
+6.29M
2025Q4
746
95.93M
55.50%
+4.67M
2025Q3
619
75.72M
43.81%
-4.20M
2025Q2
501
136.83M
81.41%
-3.18M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Blue Media, LLC
16.19M
9.32%
-1.95M
-10.74%
Dec 31, 2025
BK TL21 LLC
15.22M
8.76%
--
--
Mar 18, 2025
Lefkofsky (Eric Paul)
12.77M
7.35%
+249.84K
+2.00%
Feb 20, 2026
ARK Investment Management LLC
9.45M
5.44%
+1.89M
+24.99%
Feb 28, 2026
Gray Media, LLC
8.97M
5.17%
-299.25K
-3.23%
Dec 31, 2025
Baillie Gifford & Co.
8.74M
5.03%
-951.00K
-9.81%
Dec 31, 2025
Red Sky LLC
8.06M
4.64%
-1.44M
-15.13%
Sep 30, 2025
Catalytic Wealth RIA, LLC
6.76M
3.89%
+6.76M
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.04M
3.47%
+652.41K
+12.12%
Dec 31, 2025
SoftBank Group Corp
5.41M
3.11%
--
--
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ARK Genomic Revolution ETF
12.02%
ARK Innovation ETF
5.1%
Global X HealthTech ETF
4.22%
Franklin Genomic Advancements ETF
3.92%
Renaissance IPO ETF
3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
3.05%
AXS Green Alpha ETF
2.92%
ROBO Global Artificial Intelligence ETF
2.49%
First Trust Health Care Alphadex Fund
2.42%
Innovator IBD 50 Fund ETF
2.22%
Ver Mais
ARK Genomic Revolution ETF
Proporção12.02%
ARK Innovation ETF
Proporção5.1%
Global X HealthTech ETF
Proporção4.22%
Franklin Genomic Advancements ETF
Proporção3.92%
Renaissance IPO ETF
Proporção3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
Proporção3.05%
AXS Green Alpha ETF
Proporção2.92%
ROBO Global Artificial Intelligence ETF
Proporção2.49%
First Trust Health Care Alphadex Fund
Proporção2.42%
Innovator IBD 50 Fund ETF
Proporção2.22%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI